{
  "meta": {
    "title": "53_Renal_Replacement_Therapy",
    "url": "https://brainandscalpel.vercel.app/53-renal-replacement-therapy-13ac2f0d.html",
    "scrapedAt": "2025-11-30T12:28:51.315Z"
  },
  "questions": [
    {
      "text": "Dialysis is not an absolute indication for patients who present with which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Asterixis"
        },
        {
          "id": 2,
          "text": "Pericarditis"
        },
        {
          "id": 3,
          "text": "Uremic encephalopathy"
        },
        {
          "id": 4,
          "text": "Hyperkalemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Dialysis</strong> is not indicated in patients who initially present with hyperkalemia. It is indicated in the case of <strong>refractory hyperkalemia</strong> that has failed to respond to other modalities of treatment.</p>\n<p>Indications for dialysis can be remembered using the mnemonic <strong>AEIOU</strong>:</p>\n<ul>\n<li><strong>A</strong>cidosis - metabolic acidosis that is refractory to medical treatment.</li>\n<li><strong>E</strong>lectrolyte abnormality - refractory hyperkalemia and hypercalcemia.</li>\n<li><strong>I</strong>ntoxication - barbiturates, alcohol, and lithium.</li>\n<li><strong>O</strong>verload<strong> </strong>- hypervolemia and pulmonary edema.</li>\n<li><strong>U</strong>ncontrolled hypertension (and)</li>\n<li><strong>U</strong>remia - encephalopathy, pericarditis, asterixis, seizures, intractable nausea and vomiting, and bleeding diathesis.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2099",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most commonly used therapeutic modality for patients with end-stage renal disease?",
      "choices": [
        {
          "id": 1,
          "text": "Hemodialysis"
        },
        {
          "id": 2,
          "text": "Renal transplant"
        },
        {
          "id": 3,
          "text": "Continuous ambulatory peritoneal dialysis"
        },
        {
          "id": 4,
          "text": "Continuous cycling peritoneal dialysis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common therapeutic modality for patients with&nbsp;end-stage renal disease (<strong>ESRD</strong>) is <strong>hemodialysis.</strong></p>\n<p>The various modalities of renal replacement therapy include the following:</p>\n<ul>\n<li><strong>Dialysis:</strong>\n<ul>\n<li>Acute intermittent hemodialysis</li>\n<li>Continuous renal replacement therapy - includes hemodialysis and ultrafiltration techniques</li>\n<li>Peritoneal dialysis\n<ul>\n<li>CAPD - Continuous ambulatory&nbsp;peritoneal dialysis</li>\n<li>CCPD - Continuous cycling peritoneal dialysis</li>\n<li>NIPD - Nocturnal intermittent peritoneal dialysis</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Renal</strong> <strong>transplant</strong></li>\n</ul><hr><h3>Related Pearl: Hemodialysis vs Peritoneal dialysis</h3><p>Difference between Hemodialysis and Peritoneal dialysis</p>\n<table>\n<tbody>\n<tr>\n<td>Hemodialysis</td>\n<td>Peritoneal dialysis</td>\n</tr>\n<tr>\n<td>Comparatively difficult access</td>\n<td>Easy access</td>\n</tr>\n<tr>\n<td>Better clearance</td>\n<td>Good clearance</td>\n</tr>\n<tr>\n<td>Short time for treatment</td>\n<td>Longer time may be required</td>\n</tr>\n<tr>\n<td>Principle:<br /><br />Solute removal through a semi-permeable membrane.</td>\n<td>\n<p>Principle:</p>\n<p>Solute removal through a peritoneal membrane</p>\n</td>\n</tr>\n<tr>\n<td>Must be done in hospital</td>\n<td>Can be done at home</td>\n</tr>\n<tr>\n<td>Complications:<br />\n<ul>\n<li>Hypotension</li>\n<li>Disequilibrium syndrome</li>\n<li>Muscle cramps</li>\n<li>Anaphylaxis reaction</li>\n</ul>\n</td>\n<td>\n<p>Complications :</p>\n<ul>\n<li>Peritonitis</li>\n<li>Catheter-associated non-peritoneal infections</li>\n<li>Weight gain</li>\n<li>Metabolic disturbances</li>\n<li>Residual uremia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1465",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is incorrect about hemodialysis?​",
      "choices": [
        {
          "id": 1,
          "text": "Dialyzers are made up of cellulose membranes"
        },
        {
          "id": 2,
          "text": "Bicarbonate is commonly used as a buffer"
        },
        {
          "id": 3,
          "text": "Glutaraldehyde  is used as a reprocessing agent"
        },
        {
          "id": 4,
          "text": "Urea is cleared more efficiently than creatinine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In <strong>hemodialysis,</strong> the <strong>dialyzer</strong> is made up of biocompatible membranes derived from <strong>polysulfone.</strong>&nbsp;Cellulose is bio-incompatible and is no longer used.</p>\n<p>Hemodialysis&nbsp;is based on the principle of solute diffusion using an artificial semi-permeable membrane. Smaller molecules (<strong>urea</strong>) diffuse faster and are <strong>cleared</strong> more <strong>efficiently</strong> than larger molecules (creatinine). There are three components to this system:</p>\n<ul>\n<li>Dialyzer - a chamber that contains compartments for blood and dialysate solution, separated by a semipermeable membrane.&nbsp;</li>\n<li><strong>Dialysate</strong> - a solution that helps in the removal of metabolic waste products.&nbsp;<strong>Bicarbonate</strong> is used as a <strong>buffer</strong> to correct acidosis in CKD patients.</li>\n<li><strong>Blood delivery system</strong> - consists of the vascular access and extracorporeal circuit.</li>\n</ul>\n<p>The dialyzers used during a session of dialysis are reprocessed and reused for the next dialysis sessions. The reprocessors used for dialyzers are:&nbsp;</p>\n<ul>\n<li><strong>Glutaraldehyde</strong></li>\n<li>Formaldehyde&nbsp;&nbsp;</li>\n<li>Peracetic acid-hydrogen peroxide</li>\n</ul>\n<p>The following image depicts hemodialysis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/53e103fc130b4abb9632f647983fc3a8x654x564.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Hemodialysis vs Peritoneal dialysis</h3><p>Difference between Hemodialysis and Peritoneal dialysis</p>\n<table>\n<tbody>\n<tr>\n<td>Hemodialysis</td>\n<td>Peritoneal dialysis</td>\n</tr>\n<tr>\n<td>Comparatively difficult access</td>\n<td>Easy access</td>\n</tr>\n<tr>\n<td>Better clearance</td>\n<td>Good clearance</td>\n</tr>\n<tr>\n<td>Short time for treatment</td>\n<td>Longer time may be required</td>\n</tr>\n<tr>\n<td>Principle:<br /><br />Solute removal through a semi-permeable membrane.</td>\n<td>\n<p>Principle:</p>\n<p>Solute removal through a peritoneal membrane</p>\n</td>\n</tr>\n<tr>\n<td>Must be done in hospital</td>\n<td>Can be done at home</td>\n</tr>\n<tr>\n<td>Complications:<br />\n<ul>\n<li>Hypotension</li>\n<li>Disequilibrium syndrome</li>\n<li>Muscle cramps</li>\n<li>Anaphylaxis reaction</li>\n</ul>\n</td>\n<td>\n<p>Complications :</p>\n<ul>\n<li>Peritonitis</li>\n<li>Catheter-associated non-peritoneal infections</li>\n<li>Weight gain</li>\n<li>Metabolic disturbances</li>\n<li>Residual uremia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2084",
      "difficulty": "hard"
    },
    {
      "text": "A 50-year-old man with stage 5 chronic kidney disease is planned for hemodialysis. Which of the following is incorrect regarding the vascular access for this procedure?",
      "choices": [
        {
          "id": 1,
          "text": "Tunneled catheters are associated with lower infection rates"
        },
        {
          "id": 2,
          "text": "Access of choice is radiocephalic arteriovenous fistula"
        },
        {
          "id": 3,
          "text": "Most common complication of arteriovenous grafts is infection"
        },
        {
          "id": 4,
          "text": "Fistulas have higher long term patency rates"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most common complication of arteriovenous (<strong>AV</strong>)&nbsp;<strong>grafts</strong>&nbsp;is&nbsp;<strong>stenosis,</strong>&nbsp;not infections.</p>\n<p>In order to perform hemodialysis,&nbsp;<strong>vascular</strong>&nbsp;or&nbsp;<strong>hemodialysis access</strong>&nbsp;must first be established. The preferred site is the<strong>&nbsp;forearm.&nbsp;</strong>The following types of vascular access may be used for hemodialysis:</p>\n<ul>\n<li><strong>AV fistulas:</strong></li>\n<ul>\n<li>Fistula refers to the anastomosis of an artery and an adequately large vein (either side-to-side or end-to-side).</li>\n<li>This causes&nbsp;<strong>arterialization</strong>&nbsp;of the&nbsp;<strong>vein</strong>, thereby causing venous&nbsp;<strong>wall thickening</strong>&nbsp;and increasing venous<strong>&nbsp;diameter</strong>.</li>\n<li>Fistulas need 4-6 weeks to mature before they can be used.&nbsp;</li>\n<li>The access of choice is&nbsp;<strong>radiocephalic</strong>&nbsp;AV fistula (<strong>Brescia-Cimino</strong> fistula).</li>\n<li>Fistulas have higher&nbsp;<strong>long-term patency</strong>&nbsp;rates than grafts.</li>\n<li>Thrombosis is a common complication.</li>\n</ul>\n</ul>\n<p>The following image depicts a radiocephalic fistula.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/498dc770b601482ab4fa70887fc30a22x960x720.PNG\" alt=\"Explanation Image\"><ul>\n<li><strong>AV grafts:</strong>\n<ul>\n<li>The artery and vein are connected by a prosthetic graft such as <strong>PTFE</strong> (polytetrafluoroethylene).</li>\n<li>The advantage is that it can be performed with smaller veins.</li>\n<li>Complications include<strong> stenosis</strong>&nbsp;(most common), due to intimal hyperplasia at anastomosis between graft and vein, and <strong>infections</strong>.</li>\n</ul>\n</li>\n<li><strong>Central venous catheter</strong>:\n<ul>\n<li><strong>Tunneled</strong> catheters are used for long-term IV access. As they tunnel through the skin before entering the vein, they have a&nbsp;<strong>lower</strong>&nbsp;<strong>risk</strong>&nbsp;of&nbsp;<strong>infection.</strong></li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Hemodialysis vs Peritoneal dialysis</h3><p>Difference between Hemodialysis and Peritoneal dialysis</p>\n<table>\n<tbody>\n<tr>\n<td>Hemodialysis</td>\n<td>Peritoneal dialysis</td>\n</tr>\n<tr>\n<td>Comparatively difficult access</td>\n<td>Easy access</td>\n</tr>\n<tr>\n<td>Better clearance</td>\n<td>Good clearance</td>\n</tr>\n<tr>\n<td>Short time for treatment</td>\n<td>Longer time may be required</td>\n</tr>\n<tr>\n<td>Principle:<br /><br />Solute removal through a semi-permeable membrane.</td>\n<td>\n<p>Principle:</p>\n<p>Solute removal through a peritoneal membrane</p>\n</td>\n</tr>\n<tr>\n<td>Must be done in hospital</td>\n<td>Can be done at home</td>\n</tr>\n<tr>\n<td>Complications:<br />\n<ul>\n<li>Hypotension</li>\n<li>Disequilibrium syndrome</li>\n<li>Muscle cramps</li>\n<li>Anaphylaxis reaction</li>\n</ul>\n</td>\n<td>\n<p>Complications :</p>\n<ul>\n<li>Peritonitis</li>\n<li>Catheter-associated non-peritoneal infections</li>\n<li>Weight gain</li>\n<li>Metabolic disturbances</li>\n<li>Residual uremia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2080",
      "difficulty": "medium"
    },
    {
      "text": "What is the rate of blood flow in the hemodialysis machine?",
      "choices": [
        {
          "id": 1,
          "text": "150-250 mL/min"
        },
        {
          "id": 2,
          "text": "200-300 mL/min"
        },
        {
          "id": 3,
          "text": "250-450 mL/min"
        },
        {
          "id": 4,
          "text": "500-800 mL/min"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p class=\"p1\">During <strong>hemodialysis</strong>, heparinized <strong>blood</strong> flows through the dialyzer at a rate of <strong>250&ndash;450</strong> mL/min. On the other hand, the <strong>dialysate</strong> flows in the opposite counter-current direction at <strong>500&ndash;800 </strong>mL/min.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2077",
      "difficulty": "medium"
    },
    {
      "text": "In a patient undergoing hemodialysis, which of the following can be used to monitor the adequacy of dialysis?",
      "choices": [
        {
          "id": 1,
          "text": "Urea reduction ratio"
        },
        {
          "id": 2,
          "text": "Blood urea / creatinine ratio"
        },
        {
          "id": 3,
          "text": "Urinary protein / creatinine ratio"
        },
        {
          "id": 4,
          "text": "Creatinine reduction ratio"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The adequacy of dialysis is determined by<strong>&nbsp;</strong>the<strong>&nbsp;urea reduction ratio.&nbsp;</strong>It is defined as the fractional reduction in blood urea nitrogen per hemodialysis session. It is calculated as <strong>(C<sub>o</sub> - C) / C<sub>o,&nbsp;</sub></strong>where:</p>\n<p>C<sub>o</sub> - predialysis serum urea</p>\n<p>C - postdialysis serum urea</p>\n<p>The target urea reduction ratio is<strong>&nbsp;65&ndash;70%.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2078",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following has been most commonly implicated as a cause of dialysis-induced hypotension in patients?",
      "choices": [
        {
          "id": 1,
          "text": "Bicarbonate"
        },
        {
          "id": 2,
          "text": "Aluminium"
        },
        {
          "id": 3,
          "text": "Acetate"
        },
        {
          "id": 4,
          "text": "Phosphate"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Acetate</strong> is used as a buffer in the dialysate solution. It is the most common cause of dialysis-induced <strong>hypotension</strong> because of its <strong>vasodilatory </strong>and<strong> cardio-depressive effects.</strong></p>\n<p>For this reason, acetate is less commonly used these days and has been largely replaced by <strong>bicarbonate.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2088",
      "difficulty": "hard"
    },
    {
      "text": "What is the most common acute complication in patients who undergo hemodialysis?",
      "choices": [
        {
          "id": 1,
          "text": "Anaphylaxis"
        },
        {
          "id": 2,
          "text": "Dialysis disquillibrium syndrome"
        },
        {
          "id": 3,
          "text": "Hypotension"
        },
        {
          "id": 4,
          "text": "Muscle cramps"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Hypotension</strong> is the most common acute complication of <strong>hemodialysis</strong>,&nbsp;particularly among patients with <strong>diabetes</strong> mellitus.</p><hr><h3>Related Pearl: Hemodialysis vs Peritoneal dialysis</h3><p>Difference between Hemodialysis and Peritoneal dialysis</p>\n<table>\n<tbody>\n<tr>\n<td>Hemodialysis</td>\n<td>Peritoneal dialysis</td>\n</tr>\n<tr>\n<td>Comparatively difficult access</td>\n<td>Easy access</td>\n</tr>\n<tr>\n<td>Better clearance</td>\n<td>Good clearance</td>\n</tr>\n<tr>\n<td>Short time for treatment</td>\n<td>Longer time may be required</td>\n</tr>\n<tr>\n<td>Principle:<br /><br />Solute removal through a semi-permeable membrane.</td>\n<td>\n<p>Principle:</p>\n<p>Solute removal through a peritoneal membrane</p>\n</td>\n</tr>\n<tr>\n<td>Must be done in hospital</td>\n<td>Can be done at home</td>\n</tr>\n<tr>\n<td>Complications:<br />\n<ul>\n<li>Hypotension</li>\n<li>Disequilibrium syndrome</li>\n<li>Muscle cramps</li>\n<li>Anaphylaxis reaction</li>\n</ul>\n</td>\n<td>\n<p>Complications :</p>\n<ul>\n<li>Peritonitis</li>\n<li>Catheter-associated non-peritoneal infections</li>\n<li>Weight gain</li>\n<li>Metabolic disturbances</li>\n<li>Residual uremia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2087",
      "difficulty": "medium"
    },
    {
      "text": "A 61-year-old man is brought to the casualty following a seizure episode. His wife says that he has been very drowsy and has not passed urine for the past 2 days. Investigations reveal serum urea of 71 mg/dl and creatinine of 5.6 mg/dl. He is referred for urgent hemodialysis. You would take all of the following precautions except:",
      "choices": [
        {
          "id": 1,
          "text": "Warming the dialysate before dialysis"
        },
        {
          "id": 2,
          "text": "Removing more fluid during the beginning than the end of the procedure"
        },
        {
          "id": 3,
          "text": "Maintaining fluid removal rate below 13 mL/kg/hour"
        },
        {
          "id": 4,
          "text": "Careful evaluation of dry weight"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cooling</strong>, not warming, the dialysate before dialysis must be done to<strong> prevent hypotension</strong> during dialysis.</p>\n<p>Hypotension is the most common acute complication of hemodialysis. The mechanism is not fully understood and occurs due to multiple factors. However, the following precautions have been shown to frequently prevent this complication:</p>\n<ul>\n<li>Careful calculation of the<strong> dry weight </strong>and adjustment of the filtration rate accordingly.</li>\n<li>Ultrafiltration modeling such that&nbsp;<strong>more fluid</strong> is <strong>removed</strong> during the <strong>beginning</strong> than the end of the procedure.</li>\n<li>Avoiding rapid fluid removal and maintaining the rate <strong>&lt;&nbsp;13 mL/kg/hour</strong>.</li>\n<li>Avoiding heavy meals during dialysis.</li>\n<li>Cooling of the dialysate during the dialysis.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2089",
      "difficulty": "hard"
    },
    {
      "text": "A 67-year-old woman with CKD underwent her first session of hemodialysis. Towards the end of the session, she became drowsy and had a sudden seizure episode. What is the likely cause for this presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Hypotension"
        },
        {
          "id": 2,
          "text": "Aluminium toxicity"
        },
        {
          "id": 3,
          "text": "Anaphylaxis"
        },
        {
          "id": 4,
          "text": "Reverse urea effect"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><span>The given scenario is suggestive of the</span><span>&nbsp;<strong>dialysis disequilibrium</strong>&nbsp;syndrome or the <strong>reverse urea</strong> effect. It is an acute complication that occurs especially in patients undergoing dialysis for the first time.</span></p>\n<p><span>During dialysis, urea in blood vessels is rapidly removed as compared to that in the interstitium. This&nbsp;<strong>decreases </strong>the<strong> osmolality</strong> of blood. This results in</span><span>&nbsp;a fluid shift from the blood vessels into the interstitium and brain parenchyma, causing&nbsp;<strong>cerebral edema.&nbsp;</strong></span></p>\n<p><span>In order to prevent this, the rate of flow of dialysate must be adjusted to avoid the rapid removal of solutes.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2100",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is true about anaphylaxis associated with hemodialysis?",
      "choices": [
        {
          "id": 1,
          "text": "Occur due to lack of cellulose in the membranes"
        },
        {
          "id": 2,
          "text": "Ethylene oxide is the cause of Type B reaction"
        },
        {
          "id": 3,
          "text": "Dialysis is discontinued in Type A reaction"
        },
        {
          "id": 4,
          "text": "Type A reaction associated with complement activation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Dialysis must be discontinued immediately in case of a type A reaction. It is an IgE-mediated&nbsp;<strong>immediate hypersensitivity </strong>reaction that can lead to shock and death.</p>\n<p>Bio-incompatible <strong>cellulose</strong>-containing membranes are&nbsp;<strong>commonly associated</strong> with hemodialysis-associated anaphylaxis.</p>\n<p>The reactions can be of two types:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type A reaction</strong></td>\n<td><strong>&nbsp;Type B reaction</strong></td>\n</tr>\n<tr>\n<td>IgE-mediated immediate hypersensitivity reaction in response to <strong>ethylene oxide</strong>. (used to sterilize dialyzers).</td>\n<td>Delayed reaction due to <strong>complement</strong> <strong>activation</strong> and cytokine release.</td>\n</tr>\n<tr>\n<td>Occur within minutes.</td>\n<td>Occur after hours.</td>\n</tr>\n<tr>\n<td>\n<p><strong>Stop dialysis</strong> and give subcutaneous adrenaline or steroids.</p>\n</td>\n<td>&nbsp;It is <strong>self-limiting</strong> and dialysis can be continued.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0855",
      "difficulty": "medium"
    },
    {
      "text": "A patient on hemodialysis may develop all of the following chronic complications except:",
      "choices": [
        {
          "id": 1,
          "text": "Amyloidosis"
        },
        {
          "id": 2,
          "text": "Dementia"
        },
        {
          "id": 3,
          "text": "Bone disease"
        },
        {
          "id": 4,
          "text": "Hypovolemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Hypovolemia is an&nbsp;<strong>acute </strong>complication of <strong>hemodialysis</strong>.&nbsp;The <strong>chronic complications</strong> of hemodialysis are:</p>\n<ul>\n<li>Amyloidosis</li>\n<li>Adynamic bone disease</li>\n<li>Dementia (aluminum toxicity)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2091",
      "difficulty": "easy"
    },
    {
      "text": "A physician is evaluating a patient with carpal tunnel syndrome. He has been undergoing dialysis for the past 7 years. Deposition of which of the following is responsible for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "AA"
        },
        {
          "id": 2,
          "text": "Amyloid beta 1"
        },
        {
          "id": 3,
          "text": "Amyloid beta 2"
        },
        {
          "id": 4,
          "text": "Amyloid transthyretin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Carpal tunnel syndrome in the setting of chronic dialysis is suggestive of<strong>&nbsp;dialysis-associated amyloidosis.&nbsp;</strong>It&nbsp;occurs due to the deposition of<strong>&nbsp;amyloid &szlig;-2&nbsp;</strong>in tissues.</p>\n<p>This condition&nbsp;is seen in patients undergoing long-term hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). Amyloid deposition can lead to the following complications:</p>\n<ul>\n<li>Destructive osteoarthropathies -&nbsp;<strong>carpal tunnel syndrome</strong>, flexor tenosynovitis</li>\n<li>Subchondral <strong>bone cysts</strong> and pathologic fractures</li>\n<li><strong>Paraplegia</strong> - due to deposits along paravertebral ligaments and intervertebral discs</li>\n<li>Visceral involvement - GI tract, heart, tongue</li>\n</ul>\n<p>Management involves providing symptomatic relief by means of analgesics, anti-inflammatory drugs, physical and occupational therapy, and surgical procedures.&nbsp;Renal <strong>transplantation</strong> is the treatment of choice.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2093",
      "difficulty": "medium"
    },
    {
      "text": "A 57-year-old man is referred urgently for management of pulmonary edema. He was diagnosed with stage-5 CKD 3 weeks ago but was reluctant to start dialysis. On examination, he is confused and has a flapping tremor. Investigations are as follows. Which of his clinical features will not improve with dialysis?<div class='question-desc-html'><p>Serum urea - 99 mg/dl</p>\n<p>Serum creatinine - 5.1 mg/dl</p>\n<p>Serum calcium - 7.1 mg/dl</p>\n<p>Arterial blood gas - Metabolic acidosis</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Pulmonary edema"
        },
        {
          "id": 2,
          "text": "Metabolic acidosis"
        },
        {
          "id": 3,
          "text": "Uremic encephalopathy"
        },
        {
          "id": 4,
          "text": "Renal osteodystrophy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Renal osteodystrophy</strong>&nbsp;does not show&nbsp;improvement with dialysis<strong>.</strong></p>\n<p>Failure of renal function leads to <strong>decreased</strong> renal <strong>vitamin</strong> <strong>D</strong> <strong>production</strong>. The resulting hypocalcemia and hyperphosphatemia, in turn, lead to secondary hyperparathyroidism. This can be corrected only by vitamin D and calcium <strong>supplementation</strong>.</p>\n<p>Other manifestations of renal dysfunction and uremia show improvement with regular dialysis sessions.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2120",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common cause of death in patients undergoing chronic dialysis?",
      "choices": [
        {
          "id": 1,
          "text": "Cardiovascular causes"
        },
        {
          "id": 2,
          "text": "Electrolyte abnormality"
        },
        {
          "id": 3,
          "text": "Metabolic acidosis"
        },
        {
          "id": 4,
          "text": "Encephalopathy"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cardiovascular </strong>disease due to<strong> accelerated atherosclerosis </strong>is the major cause of death in patients with <strong>ESRD</strong> on <strong>chronic dialysis</strong>.</p>\n<p class=\"p1\">Cardiovascular mortality is higher in dialysis patients compared to patients after transplantation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2104",
      "difficulty": "medium"
    },
    {
      "text": "You are educating a patient about performing peritoneal dialysis at home. During this process, how much fluid is infused into the peritoneum?",
      "choices": [
        {
          "id": 1,
          "text": "1.5-3 L"
        },
        {
          "id": 2,
          "text": "2-4 L"
        },
        {
          "id": 3,
          "text": "3-5 L"
        },
        {
          "id": 4,
          "text": "0.5-1.5 L"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In peritoneal dialysis,&nbsp;<strong>1.5&ndash;3 L</strong> of dialysis fluid is infused into the peritoneal cavity.&nbsp;</p>\n<p>In this process, the peritoneum itself acts as a semipermeable membrane. A <strong>peritoneal catheter&nbsp;</strong>is used to infuse the fluid into the cavity.&nbsp;It is allowed to dwell for a set period of time usually <strong>2&ndash;4 hours</strong>&nbsp;to allow for the removal of metabolic waste products.<strong>&nbsp;</strong>The dialysis fluid contains osmotically active agents such as glucose&nbsp;or icodextrin.</p>\n<p>The following image shows the process of peritoneal dialysis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/203da591884e41c9a8aa8fd28a1db205x592x555.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Hemodialysis vs Peritoneal dialysis</h3><p>Difference between Hemodialysis and Peritoneal dialysis</p>\n<table>\n<tbody>\n<tr>\n<td>Hemodialysis</td>\n<td>Peritoneal dialysis</td>\n</tr>\n<tr>\n<td>Comparatively difficult access</td>\n<td>Easy access</td>\n</tr>\n<tr>\n<td>Better clearance</td>\n<td>Good clearance</td>\n</tr>\n<tr>\n<td>Short time for treatment</td>\n<td>Longer time may be required</td>\n</tr>\n<tr>\n<td>Principle:<br /><br />Solute removal through a semi-permeable membrane.</td>\n<td>\n<p>Principle:</p>\n<p>Solute removal through a peritoneal membrane</p>\n</td>\n</tr>\n<tr>\n<td>Must be done in hospital</td>\n<td>Can be done at home</td>\n</tr>\n<tr>\n<td>Complications:<br />\n<ul>\n<li>Hypotension</li>\n<li>Disequilibrium syndrome</li>\n<li>Muscle cramps</li>\n<li>Anaphylaxis reaction</li>\n</ul>\n</td>\n<td>\n<p>Complications :</p>\n<ul>\n<li>Peritonitis</li>\n<li>Catheter-associated non-peritoneal infections</li>\n<li>Weight gain</li>\n<li>Metabolic disturbances</li>\n<li>Residual uremia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2122",
      "difficulty": "medium"
    },
    {
      "text": "A 56-year-old man presents with fever and severe abdominal pain for 2 days. He has been on peritoneal dialysis for the past 1 year. On examination, there is abdominal distension, guarding, and rebound tenderness. Which of the following is the most common cause of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Gram-positive cocci"
        },
        {
          "id": 2,
          "text": "Gram-positive bacilli"
        },
        {
          "id": 3,
          "text": "Gram-negative cocci"
        },
        {
          "id": 4,
          "text": "Gram-negative bacilli"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This clinical scenario in a patient undergoing peritoneal dialysis&nbsp;is suggestive of <strong>peritonitis</strong>. It is most commonly caused by&nbsp;<strong>gram-positive cocci </strong>such as<strong>&nbsp;<em>Staphylococcus</em></strong>, which spread from the skin.</p><hr><h3>Related Pearl: Hemodialysis vs Peritoneal dialysis</h3><p>Difference between Hemodialysis and Peritoneal dialysis</p>\n<table>\n<tbody>\n<tr>\n<td>Hemodialysis</td>\n<td>Peritoneal dialysis</td>\n</tr>\n<tr>\n<td>Comparatively difficult access</td>\n<td>Easy access</td>\n</tr>\n<tr>\n<td>Better clearance</td>\n<td>Good clearance</td>\n</tr>\n<tr>\n<td>Short time for treatment</td>\n<td>Longer time may be required</td>\n</tr>\n<tr>\n<td>Principle:<br /><br />Solute removal through a semi-permeable membrane.</td>\n<td>\n<p>Principle:</p>\n<p>Solute removal through a peritoneal membrane</p>\n</td>\n</tr>\n<tr>\n<td>Must be done in hospital</td>\n<td>Can be done at home</td>\n</tr>\n<tr>\n<td>Complications:<br />\n<ul>\n<li>Hypotension</li>\n<li>Disequilibrium syndrome</li>\n<li>Muscle cramps</li>\n<li>Anaphylaxis reaction</li>\n</ul>\n</td>\n<td>\n<p>Complications :</p>\n<ul>\n<li>Peritonitis</li>\n<li>Catheter-associated non-peritoneal infections</li>\n<li>Weight gain</li>\n<li>Metabolic disturbances</li>\n<li>Residual uremia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2125",
      "difficulty": "medium"
    },
    {
      "text": "A woman is started on continuous ambulatory peritoneal dialysis. Which of the following complications is she unlikely to develop?",
      "choices": [
        {
          "id": 1,
          "text": "Residual uremia"
        },
        {
          "id": 2,
          "text": "Metabolic disturbances"
        },
        {
          "id": 3,
          "text": "Insulin resistance"
        },
        {
          "id": 4,
          "text": "Weight loss"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Weight gain</strong> is a complication of <strong>peritoneal dialysis</strong>, not weight loss. The complications of peritoneal dialysis include:</p>\n<ul>\n<li>Peritonitis</li>\n<li>Catheter-associated non-peritonitis infections </li>\n<li>Weight gain</li>\n<li>Metabolic disturbances - <strong>hypoproteinemia</strong> and <strong>hyperglycemia</strong></li>\n<li><strong>Residual uremia</strong> - especially among patients with no residual kidney function</li>\n<li><strong>Insulin resistance</strong></li>\n<li>Hypertriglyceridemia</li>\n</ul><hr><h3>Related Pearl: Hemodialysis vs Peritoneal dialysis</h3><p>Difference between Hemodialysis and Peritoneal dialysis</p>\n<table>\n<tbody>\n<tr>\n<td>Hemodialysis</td>\n<td>Peritoneal dialysis</td>\n</tr>\n<tr>\n<td>Comparatively difficult access</td>\n<td>Easy access</td>\n</tr>\n<tr>\n<td>Better clearance</td>\n<td>Good clearance</td>\n</tr>\n<tr>\n<td>Short time for treatment</td>\n<td>Longer time may be required</td>\n</tr>\n<tr>\n<td>Principle:<br /><br />Solute removal through a semi-permeable membrane.</td>\n<td>\n<p>Principle:</p>\n<p>Solute removal through a peritoneal membrane</p>\n</td>\n</tr>\n<tr>\n<td>Must be done in hospital</td>\n<td>Can be done at home</td>\n</tr>\n<tr>\n<td>Complications:<br />\n<ul>\n<li>Hypotension</li>\n<li>Disequilibrium syndrome</li>\n<li>Muscle cramps</li>\n<li>Anaphylaxis reaction</li>\n</ul>\n</td>\n<td>\n<p>Complications :</p>\n<ul>\n<li>Peritonitis</li>\n<li>Catheter-associated non-peritoneal infections</li>\n<li>Weight gain</li>\n<li>Metabolic disturbances</li>\n<li>Residual uremia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2128",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is incorrect about renal transplants?",
      "choices": [
        {
          "id": 1,
          "text": "ABO and HLA mismatch are relative contraindications"
        },
        {
          "id": 2,
          "text": "Contraindicated in overt AIDS and active hepatitis"
        },
        {
          "id": 3,
          "text": "Complications in donor include hypertension and focal segmental glomerulosclerosis"
        },
        {
          "id": 4,
          "text": "The most common cause of death after renal transplant is infections"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most common cause of death in&nbsp;<strong>renal transplant&nbsp;recipients</strong> is <strong>cardiovascular </strong>causes.<strong>&nbsp;</strong>It occurs in <strong>&gt; 50%</strong> of patients.</p>\n<p>Other complications in recipients include:</p>\n<ul>\n<li>Infections&nbsp;\n<ul>\n<li>Most common - CMV.</li>\n<li>Most specific - BK (polyoma) virus</li>\n<li>Most common fungal - pneumocystis.</li>\n</ul>\n</li>\n<li>Malignancy<strong> - </strong>most commonly of skin and lip</li>\n</ul>\n<p><strong>Donors</strong> can develop long-term complications related to <strong>premature failure</strong> of the single remaining kidney including:</p>\n<ul>\n<li>Hypertension</li>\n<li>Proteinuria</li>\n<li>Focal segmental glomerulosclerosis (<strong>FSGS</strong>)</li>\n</ul>\n<p><strong>ABO</strong> and <strong>HLA</strong> mismatch<strong>&nbsp;</strong>are <strong>relative</strong>, not absolute <strong>contraindications</strong> due to the availability of desensitization procedures. The <strong>absolute</strong> <strong>contraindications</strong> for transplantation are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Recipient</strong></td>\n<td><strong>Donor</strong></td>\n</tr>\n<tr>\n<td>Any active infections/ malignancy</td>\n<td>Any active infections (including HIV)/ malignancy</td>\n</tr>\n<tr>\n<td>Shortened life expectancy due to other causes</td>\n<td>Uncontrolled diabetes/ hypertension</td>\n</tr>\n<tr>\n<td>Active substance abuse/ uncontrolled psychiatric condition</td>\n<td>Uncontrolled psychiatric condition or suicidality</td>\n</tr>\n<tr>\n<td>Treatment nonadherence</td>\n<td>Age &lt; 18 or lack of mental capacity</td>\n</tr>\n<tr>\n<td>Reversible renal failure</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0859",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is incorrect about rejection reactions following a kidney transplant?",
      "choices": [
        {
          "id": 1,
          "text": "Acute rejection can occur due to both type 4 and type 2 hypersensitivity reactions"
        },
        {
          "id": 2,
          "text": "Hyperacute rejection is a type 2 hypersensitivity reaction"
        },
        {
          "id": 3,
          "text": "Induction therapy for prophylaxis of rejection is cyclosporine, azathioprine, prednisolone."
        },
        {
          "id": 4,
          "text": "Alemtuzumab  is  monoclonal antibody against CD52 used for immunosuppression"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Cyclosporine,</strong> <strong>azathioprine</strong>, <strong>prednisolone&nbsp;</strong>constitute<strong>&nbsp;</strong>the prophylactic<strong> maintenance </strong>therapy&nbsp;used after renal transplant.</p>\n<p>Immunosuppressive therapy is given to reduce the risk of transplant rejection reactions. The following regimen is commonly followed:</p>\n<ul>\n<li><strong>Induction </strong>therapy<strong>: </strong>\n<ul>\n<li>Given at the time of transplant&nbsp;to reduce the risk of early acute rejection.</li>\n<li>The preferred treatment is <strong>anti-lymphocyte serum</strong> and <strong>alemtuzumab</strong>.</li>\n</ul>\n</li>\n<li><strong>Maintenance </strong>therapy:&nbsp;\n<ul>\n<li>Given to all kidney transplant patients except when the donor and recipient are identical twins.</li>\n<li>The most common combination used is :<br />cyclosporine, azathioprine, and prednisolone (also known as <strong>triple therapy</strong>).</li>\n<li><strong>Belatacept</strong> is a co-stimulatory blocking antibody approved by the FDA for maintenance therapy.</li>\n</ul>\n</li>\n</ul>\n<p>Rejection reactions can be hyperacute, acute, or chronic. Treatment of <strong>rejection</strong> is as follows:</p>\n<ul>\n<li>First episode - IV <strong>prednisolone</strong> for 3 days</li>\n<li>Failure to respond to prednisone or second episode - <strong>anti-thymocyte globulin</strong>&nbsp;</li>\n</ul><hr><h3>Related Pearl: Transplant Rejection and Hypersensitivity</h3><table>\n<tbody>\n<tr>\n<td>Type of Rejection&nbsp;</td>\n<td>Type of Hypersensitivity</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p><strong>Host vs Graft</strong></p>\n</td>\n</tr>\n<tr>\n<td>Hyperacute</td>\n<td>Type 2</td>\n</tr>\n<tr>\n<td>Acute</td>\n<td>Type 2 and 4</td>\n</tr>\n<tr>\n<td>Chronic</td>\n<td>Type 2 and 4</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Graft vs Host</strong></td>\n</tr>\n<tr>\n<td>Graft vs host reaction</td>\n<td>Type 4</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>The image given below explains the pathophysiology of hyperacute graft rejection (<strong>type II</strong> hypersensitivity).&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/988706e6c52640cabe45b6c598d1b709x1280x2089.JPEG\" alt=\"Pearl Image\"><p>The image below shows the mechanism of<strong> type IV</strong> hypersensitivity in graft rejection.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/740d6c7dadda46d38620f36124adea54x1280x4218.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Classification of Transplant Rejection Reactions</h3><p><strong>Hyperacute</strong>&nbsp;rejection<strong> (minutes to hours):</strong></p>\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism:&nbsp;<strong>Antidonor antibodies</strong> present in the circulation of the recipient</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li>Grossly, cyanotic and mottled graft with pale white areas</li>\n<li>Neutrophils accumulate</li>\n<li>Acute fibrinoid necrosis of vessel walls or complete occlusion by thrombi</li>\n</ul>\n</li>\n</ul>\n<p><strong>Acute</strong>&nbsp;rejection<strong> (days to weeks):</strong></p>\n<ol>\n<li class=\"page\" title=\"Page 246\">Acute<strong> cellular</strong> rejection (acute T cell-mediated rejection):&nbsp;&nbsp;\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism:&nbsp;<strong>CD8+ CTLs</strong> directly destroy graft or <strong>CD4+</strong> cells secrete cytokines that damage graft.</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li><strong>Tubulointerstitial pattern (type I):</strong> extensive interstitial and tubular inflammation associated with focal tubular injury</li>\n<li><strong>Vascular pattern </strong>- Inflammation (type II) and necrosis (type III): <strong>Endotheliitis</strong> (swollen endothelial cells with lymphocytes between endothelium and vessel wall)</li>\n</ul>\n</li>\n</ul>\n</li>\n<li>Acute<strong> antibody-mediated</strong> (humoral) rejection:&nbsp;\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism: antibodies bind to endothelium and activate complement causing damage and graft failure</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li>Inflammation of glomeruli and peritubular capillaries.</li>\n<li>Activation of the antibody-dependent classical complement pathway.</li>\n<li>Focal thrombosis in small vessels.&nbsp;</li>\n</ul>\n</li>\n</ul>\n</li>\n</ol>\n<p><strong>Chronic</strong>&nbsp;rejection<strong> (months to years):</strong></p>\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism:&nbsp;<strong>T-cells</strong> react against alloantigens and secrete cytokines which stimulate <strong>fibroblasts</strong> and <strong>vascular smooth muscle cells</strong> (graft arteriosclerosis). Chronic rejection may also be <strong>antibody-mediated</strong>.</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li>Predominantly vascular changes (intimal thickening and vascular occlusion)</li>\n<li>Glomerulopathy with duplication of basement membrane</li>\n<li>Interstitial fibrosis and tubular atrophy with loss of renal parenchyma</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0860",
      "difficulty": "hard"
    },
    {
      "text": "A 45-year-old man with polycystic kidney disease underwent renal transplantation 3 months ago. Which of the following infections is he at the highest risk of?",
      "choices": [
        {
          "id": 1,
          "text": "Candida"
        },
        {
          "id": 2,
          "text": "Pneumocystis"
        },
        {
          "id": 3,
          "text": "BK virus"
        },
        {
          "id": 4,
          "text": "Cytomegalovirus"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most common opportunistic infection occurring&nbsp;<strong>1-6 months</strong> after renal transplant is <em><strong>Cytomegalovirus</strong></em> (CMV).</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"3\"><strong>Opportunistic infections after renal transplant</strong></td>\n</tr>\n<tr>\n<td><strong>&lt; 1 month</strong></td>\n<td><strong>1-6 months</strong></td>\n<td><strong>&gt; 6 months</strong></td>\n</tr>\n<tr>\n<td>\n<p>Wound infections</p>\n<p>Herpesvirus</p>\n<p>Oral candidiasis&nbsp;</p>\n<p>Urinary tract infection</p>\n</td>\n<td>\n<p><em>Pneumocystis carinii&nbsp;</em></p>\n<p><em>Cytomegalovirus</em></p>\n<p><em>Legionella</em></p>\n<p><em>Listeria</em></p>\n<p>Hepatitis B,&nbsp;C</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><em>Aspergillus</em></p>\n<p><em>Nocardia</em></p>\n<p>BK virus</p>\n<p><em>Herpes zoster</em></p>\n<p>Hepatitis B, C</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><em>Pneumocystis carinii&nbsp;</em>is rare these days due to universal prophylaxis for 6-12 months following transplantation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2134",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following lesions does not recur in the transplanted kidney?",
      "choices": [
        {
          "id": 1,
          "text": "Diabetic nephropathy"
        },
        {
          "id": 2,
          "text": "Membranous glomerulonephritis"
        },
        {
          "id": 3,
          "text": "Lupus nephritis"
        },
        {
          "id": 4,
          "text": "Alport syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Alport syndrome</strong> does not recur in the transplanted kidney. This is because it occurs due to an inherited <strong>defect</strong> in <strong>type 4 collagen</strong> in the glomerular basement membrane. This defect is absent in the transplanted kidney. </p>\n<p>Diabetic nephropathy, membranous glomerulonephritis, and lupus nephritis can recur in the transplanted kidney.</p>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2130",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following conditions have the highest risk of disease recurrence after renal transplant?",
      "choices": [
        {
          "id": 1,
          "text": "Lupus nephritis"
        },
        {
          "id": 2,
          "text": "Membranoproliferative glomerulonephritis"
        },
        {
          "id": 3,
          "text": "Diabetic nephropathy"
        },
        {
          "id": 4,
          "text": "Membranous glomerulonephritis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Patients with <strong>diabetic nephropathy</strong> have&nbsp;the <strong>highest </strong>risk of disease <strong>recurrence</strong> after renal <strong>transplant.</strong> Nearly <strong>52%</strong> of transplant recipients have histological&nbsp;evidence of diabetic kidney disease/mesangial sclerosis at 10 years after transplantation.</p>\n<p>The recurrence rates of the other conditions are as follows:</p>\n<ul>\n<li>Membranoproliferative glomerulonephritis: 20-48%</li>\n<li>Membranous glomerulonephritis: 10-45%</li>\n<li>Lupus nephritis: 2-11%</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2131",
      "difficulty": "medium"
    },
    {
      "text": "What is the average life expectancy in patients following a living-donor kidney transplant?",
      "choices": [
        {
          "id": 1,
          "text": "10 years"
        },
        {
          "id": 2,
          "text": "14 years"
        },
        {
          "id": 3,
          "text": "18 years"
        },
        {
          "id": 4,
          "text": "20 years"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\">The average life expectancy of a <strong>living-donor graft</strong> is around <strong>14 years</strong> and that of a <strong>deceased-donor graft</strong> is around <strong>10 years.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0861",
      "difficulty": "hard"
    }
  ]
}